| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.065 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |